Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications

Cites (303)

Items 201–302 of 302

1. Xanthurenic acid distribution, transport, accumulation and release in the rat brain
   Serge Gobaille, Véronique Kemmel, Daniel Brumaru, Christophe Dugave, Dominique Aunis, Michel Maître · 2008 · Journal of Neurochemistry
2. Peripheral and central levels of kynurenic acid in bipolar disorder subjects and healthy controls
   Carl M. Sellgren, Jessica Gracias, Oscar Jungholm, Roy H. Perlis, Göran Engberg, Lilly Schwieler, Mikael Landén, Sophie Erhardt · 2019 · Translational Psychiatry
3. Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer’s disease
   Pratishtha Chatterjee, Henrik Zetterberg, Kathryn G. Goozee, Chai K. Lim, Kelly R. Jacobs, Nicholas James Ashton, Abdul Hye, Steve Pedrini, Hamid Reza Sohrabi, Tejal M. Shah et al. · 2019 · Journal of Neuroinflammation
4. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine
   Yu Sun, Wayne Curtis Drevets, Gustavo Turecki, Qingqin S. Li · 2020 · Brain Behavior and Immunity
5. Quinolinic acid injection in mouse medial prefrontal cortex affects reversal learning abilities, cortical connectivity and hippocampal synaptic plasticity
   Amira Latif‐Hernandez, Disha Shah, Tariq Ahmed, Adrian C. Lo, Zsuzsanna Callaerts‐Vegh, Annemie Van der Linden, Detlef Balschun, Rudi D’Hooge · 2016 · Scientific Reports
6. Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers
   Farzi, Aitak, Reichmann, Florian, Meinitzer, Andreas, Mayerhofer, Raphaela, Jain, Piyush, Hassan, Ahmed M., Fröhlich, Esther E., Wagner, Karin, Painsipp, Evelin, Rinner, Beate et al. · 2015 · Brain Behavior and Immunity
7. The impact of electroconvulsive therapy on the tryptophan–kynurenine metabolic pathway
   Sinan Gülöksüz, Baer M.G. Arts, Sharon Walter, Marjan Drukker, Laura Rodriguez, Aye-Mu Myint, Markus Schwarz, Rudolf Ponds, Jim van Os, Günter Kenis et al. · 2015 · Brain Behavior and Immunity
8. Systematic Review on the Involvement of the Kynurenine Pathway in Stroke: Pre-clinical and Clinical Evidence
   Gabriela Delevati Colpo, Venugopal Reddy Venna, Louise D. McCullough, Antônio Lúcio Teixeira · 2019 · Frontiers in Neurology
9. Microbial regulation of hippocampal miRNA expression: implications for transcription of kynurenine pathway enzymes
   Moloney, Gerard M., O’Leary, Olivia F., Salvo-Romero, Eloisa, Desbonnet, Lieve, Shanahan, Fergus, Dinan, Timothy G., Clarke, Gerard, Cryan, John F. · 2017 · Behavioural Brain Research
10. Kynurenine signaling through the aryl hydrocarbon receptor maintains the undifferentiated state of human embryonic stem cells
    Takako Yamamoto, Kunitada Hatabayashi, Mao Arita, Nobuyuki Yajima, Chiemi Takenaka, Takashi Suzuki, Masatoshi Takahashi, Yasuhiro Oshima, Keisuke Hara, Kenichi Kagawa et al. · 2019 · Science Signaling
11. Trafficking of immune cells across the blood-brain barrier is modulated by neurofibrillary pathology in tauopathies
    Petra Majerová, Alena Michalicová, Martin Cente, Jozef Hanes, Jozef Vegh, Ágnes Kittel, Nina Kosikova, Viera Cigánková, Sandra Mihaljević, Santosh Jadhav et al. · 2019 · PLoS ONE
12. Cognitive Dysfunction Precedes the Onset of Motor Symptoms in the MitoPark Mouse Model of Parkinson’s Disease
    Xiuhua Li, Laney Redus, Cang Chen, Paul Anthony Martinez, Randy Strong, Senlin Li, Jason C. O’Connor · 2013 · PLoS ONE
13. The kynurenine pathway in major depression: Haplotype analysis of three related functional candidate genes
    Claes, Stephan, Myint, Aye-Mu, Domschke, Katharina, Del-Favero, Jurgen, Entrich, Kathrin, Engelborghs, Sebastiaan, De Deyn, Peter, Mueller, Norbert, Baune, Bernhard, Rothermundt, Matthias · 2011 · Psychiatry Research
14. Relevance of Alternative Routes of Kynurenic Acid Production in the Brain
    L. A. Ramos-Chávez, R. Lugo Huitrón, D. G. Esquivel, B. Pineda, C. Ríos, D. Silva-Adaya, L. Sánchez-Chapul, G. Roldán-Roldán, V. Pérez de la Cruz · 2018 · Oxidative Medicine and Cellular Longevity
15. Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia
    Levente Gellért, János Fuzik, Anikó Göblös, Kitti Sárközi, Máté Marosi, Zsolt Kis, Tamás Farkas, István Szatmári, Ferenc Fülöp, László Vécsei et al. · 2011 · European Journal of Pharmacology
16. Delayed Increases in Regional Brain Quinolinic Acid Follow Transient Ischemia in the Gerbil
    Melvyn P. Heyes, Thaddeus S. Nowak · 1990 · Journal of Cerebral Blood Flow & Metabolism
17. Modulation of Hippocampal Synaptic Transmission by the Kynurenine Pathway Member Xanthurenic Acid and Other VGLUT Inhibitors
    Stuart A. Neale, Caroline S. Copeland, Victor N. Uebele, FIONA J. THOMSON, T.E. Salt · 2013 · Neuropsychopharmacology
18. The novel KMO inhibitor CHDI-340246 leads to a restoration of electrophysiological alterations in mouse models of Huntington's disease
    Vahri Beaumont, Ladislav Mrzljak, Ulrike Dijkman, Robert Freije, Mariette Heins, Arash Rassoulpour, Geoffrey C. Tombaugh, Simon Gelman, Amyaouch Bradaïa, Esther Steidl et al. · 2016 · Experimental Neurology
19. Chronic Mild Stress Alters Kynurenine Pathways Changing the Glutamate Neurotransmission in Frontal Cortex of Rats
    David Martín‐Hernández, Hiram Tendilla‐Beltrán, José L. M. Madrigal, Borja García‐Bueno, Juan Carlos Leza, Javier R. Caso · 2018 · Molecular Neurobiology
20. A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
    Shaowei Zhang, Michiyo Sakuma, Girdhar Singh Deora, Colin Levy, Alex D. Klausing, Carlo Breda, Kevin D. Read, Chris D. Edlin, Benjamin P. Ross, Marina Wright Muelas et al. · 2019 · Communications Biology
21. 3-Hydroxyanthralinic acid metabolism controls the hepatic SREBP/lipoprotein axis, inhibits inflammasome activation in macrophages, and decreases atherosclerosis in Ldlr−/− mice
    Martin Berg, Konstantinos A. Polyzos, Hanna E. Agardh, Roland Baumgartner, María J. Forteza, Ilona Kareinen, Anton Gisterå, Gerhard Böttcher, Eva Hurt‐Camejo, Göran K. Hansson et al. · 2019 · Cardiovascular Research
22. Role of astrocytes in memory and psychiatric disorders
    Rodrigo Moraga‐Amaro, Juan Manuel Jerez-Baraona, Felipe Simón, Jimmy Stehberg · 2014 · Journal of Physiology-Paris
23. Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress
    Lucia García‐Lara, Francisca Pérez‐Severiano, Dinora F. González‐Esquivel, Guillermo Elizondo, José Segovia · 2015 · Journal of Neuroscience Research
24. Regulation of proinflammatory monocyte activation by the kynurenine–AhR axis underlies immunometabolic control of depressive behavior in mice
    Xiaojie Zang, Xiao Zheng, Yuanlong Hou, Miaomiao Hu, Hong Wang, Xiaoqiang Bao, Fang Zhou, Guangji Wang, Haiping Hao · 2017 · The FASEB Journal
25. Actions of Xanthurenic Acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus
    Caroline S. Copeland, Stuart A. Neale, T.E. Salt · 2012 · Neuropharmacology
26. The ACMSD gene, involved in tryptophan metabolism, is mutated in a family with cortical myoclonus, epilepsy, and parkinsonism
    J.F. Martí-Massó, Alberto Bergareche, Vladimir Makarov, Javier Ruiz‐Martínez, Ana Gorostidi, Adolfo López de Munaín, Juan José Poza, Pasquale Striano, Joseph D. Buxbaum, Coro Paisán‐Ruiz · 2013 · Journal of Molecular Medicine
27. Xanthurenic Acid Formation from 3-Hydroxykynurenine in the Mammalian Brain: Neurochemical Characterization and Physiological Effects
    Korrapati V. Sathyasaikumar, Margarita A. Tararina, Hui‐Qiu Wu, Stuart A. Neale, Filippo Weisz, T.E. Salt, Robert M. Schwarcz · 2017 · Neuroscience
28. Kynurenine pathway metabolism and the neurobiology of treatment-resistant depression: Comparison of multiple ketamine infusions and electroconvulsive therapy
    Andrew P. Allen, Maura Naughton, Joshua L. Dowling, Annabel E. L. Walsh, R. O'Shea, George Shorten, Lucinda V. Scott, Declan M. McLoughlin, John F. Cryan, Gerard A. Clarke et al. · 2018 · Journal of Psychiatric Research
29. Intraventricular infusion of quinolinic acid impairs spatial learning and memory in young rats: a novel mechanism of lead-induced neurotoxicity
    Abdur Rahman, M.S. Rama Rao, Khalid M. Khan · 2018 · Journal of Neuroinflammation
30. Cinnabarinic acid, an endogenous agonist of type-4 metabotropic glutamate receptor, suppresses experimental autoimmune encephalomyelitis in mice
    Francesco Fazio, Cristina Zappulla, Serena Notartomaso, Carla Letizia Busceti, Alban Bessede, Pamela Scarselli, Carmine Vacca, Marco Gargaro, Claudia Volpi, M. Allegrucci et al. · 2014 · Neuropharmacology
31. Microglia activation contributes to quinolinic acid-induced neuronal excitotoxicity through TNF-α
    Feng, Wei, Wang, Yan, Liu, Zi-Qi, Zhang, Xuan, Han, Rong, Miao, You-Zhu, Qin, Zheng-Hong · 2017 · Apoptosis
32. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats
    Ajeesh Koshy Cherian, Howard J. Gritton, David E. Johnson, Damon A. Young, Rouba Kozak, Martin F. Sarter · 2014 · Neuropharmacology
33. Antiviral, cytotoxic and apoptotic activities of picolinic acid on human immunodeficiency virus-1 and human herpes simplex virus-2 infected cells.
    J. A. Fernandez‐Pol, Dennis J. Klos, P D Hamilton · 2002 · PubMed
34. Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia
    Ikwunga Wonodi, Robert P. McMahon, Nithin Krishna, Braxton D. Mitchell, Judy Liu, Matthew Glassman, Liyi Elliot Hong, James M. Gold · 2014 · Schizophrenia Research
35. Kynurenic Acid Restores Nrf2 Levels and Prevents Quinolinic Acid-Induced Toxicity in Rat Striatal Slices
    Fernanda Silva Ferreira, Helena Biasibetti, Paula Pierozan, Felipe Schmitz, Carolina Gessinger Bertó, Caroline A. Prezzi, Vanusa Manfredini, Ângela Terezinha de Souza Wyse · 2018 · Molecular Neurobiology
36. Tryptophan metabolite concentrations in depressed patients before and after electroconvulsive therapy
    Karen M. Ryan, Kelly Ann Allers, Declan M. McLoughlin, Andrew Harkin · 2019 · Brain Behavior and Immunity
37. Antimicrobial activity of picolinic acid against extracellular and intracellular Mycobacterium avium complex and its combined activity with clarithromycin, rifampicin and fluoroquinolones
    Shanshan Cai, Katsumasa Sato, Toshiaki Shimizu, Seiko Yamabe, Miho Hiraki, Chiaki Sano, Haruaki Tomioka · 2005 · Journal of Antimicrobial Chemotherapy
38. Kynurenic Acid Levels in Cerebrospinal Fluid from Patients with Alzheimer's Disease or Dementia with Lewy Bodies
    Malin Wennström, Henrietta M. Nielsen, Funda Orhan, Elisabet Londos, Lennart Minthon, Sophie Erhardt · 2014 · International Journal of Tryptophan Research
39. Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression‐like behavior
    A. Eskelund, Yan Li, D. Budac, H. Müller, M. Gulinello, C. Sánchez, G. Wegener · 2017 · Journal of Neurochemistry
40. The inhibition of the kynurenine pathway prevents behavioral disturbances and oxidative stress in the brain of adult rats subjected to an animal model of schizophrenia
    Gislaine Z. Réus, Indianara Reynaud Toreti Becker, Giselli Scaini, Fabricia Cardoso Petronilho, Jean Pierre Oses, Rima F Kaddurah-Daouk, Luciane Bisognin Ceretta, Alexandra Ioppi Zugno, Felipe Dal‐Pizzol, João Quevedo et al. · 2017 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
41. Kynurenine 3-mono-oxygenase inhibitors reduce glutamate concentration in the extracellular spaces of the basal ganglia but not in those of the cortex or hippocampus
    Flavio Moroni, Andrea Cozzi, R. Carpendo, Gianluca Cipriani, O. Veneroni, Emanuela Izzo · 2005 · Neuropharmacology
42. Association study between kynurenine 3‐monooxygenase gene and schizophrenia in the Japanese population
    N. Aoyama, Nagahide Takahashi, Susumu Saito, N. Maeno, R. Ishihara, Xiaohui Ji, Hideki Miura, Masashi Ikeda, Taroh Suzuki, Tsuyoshi Kitajima et al. · 2006 · Genes Brain & Behavior
43. The Janus faces of 3-hydroxykynurenine: Dual redox modulatory activity and lack of neurotoxicity in the rat striatum
    Ana Laura Colín-González, Marisol Maya-López, José Pedraza‐Chaverrí, Syed F. Ali, Anahí Chavarría, Abel Santamarı́a · 2014 · Brain Research
44. Common genetic variation in the indoleamine-2,3-dioxygenase genes and antidepressant treatment outcome in major depressive disorder
    Jessica A Cutler, Augustus John Rush, Francis J. McMahon, Gonzalo Laje · 2012 · Journal of Psychopharmacology
45. Regulation of GABAergic Inputs to CA1 Pyramidal Neurons by Nicotinic Receptors and Kynurenic Acid
    Jyotirmoy Banerjee, Manickavasagom Alkondon, Edna F. R. Pereira, Edson Xavier Albuquerque · 2012 · Journal of Pharmacology and Experimental Therapeutics
46. Biochemical identification and crystal structure of kynurenine formamidase fromDrosophila melanogaster
    Qian Han, Howard H. Robinson, Jianyong Li · 2012 · Biochemical Journal
47. Vasorelaxing Action of the Kynurenine Metabolite, Xanthurenic Acid: The Missing Link in Endotoxin-Induced Hypotension?
    Francesco Fazio, Albino Carrizzo, Luana Lionetto, Antonio Damato, Luca Capocci, Mariateresa Ambrosio, Giuseppe Battaglia, Valeria Bruno, Michele Madonna, Maurizio Simmaco et al. · 2017 · Frontiers in Pharmacology
48. Role of human brain microvascular endothelial cells during central nervous system infection
    Rüdiger Adam, Daniel Rüßing, Ortwin Adams, Aziz Ailyati, Kwang Sik Kim, Horst Schroten, Walter Däubener · 2005 · Thrombosis and Haemostasis
49. Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex
    David M. Bortz, Hui‐Qiu Wu, Robert M. Schwarcz, John P. Bruno · 2017 · Neuropharmacology
50. Acute tryptophan depletion reduces kynurenine levels: implications for treatment of impaired visuospatial memory performance in irritable bowel syndrome
    Paul J. Kennedy, Andrew P. Allen, Ann O’Neill, Eamonn M.M. Quigley, John F. Cryan, Timothy G. Dinan, Gerard A. Clarke · 2014 · Psychopharmacology
51. Chronic Treatment with the IDO1 Inhibitor 1-Methyl-D-Tryptophan Minimizes the Behavioural and Biochemical Abnormalities Induced by Unpredictable Chronic Mild Stress in Mice - Comparison with Fluoxetine
    A. Laugeray, J. Launay, J. Callebert, O. Mutlu, G. Guillemin, C. Belzung, P. Barone · 2016 · PLoS ONE
52. 3-Hydroxykynurenine and 3-Hydroxyanthranilic Acid Enhance the Toxicity Induced by Copper in Rat Astrocyte Culture
    D. Ramírez-Ortega, Alelí Ramiro-Salazar, D. González-Esquivel, C. Ríos, B. Pineda, V. Pérez de la Cruz · 2017 · Oxidative Medicine and Cellular Longevity
53. Inhibition of the kynurenine pathway protects against reactive microglial‐associated reductions in the complexity of primary cortical neurons
    K. O'Farrell, E. Fagan, T. Connor, A. Harkin · 2017 · European Journal of Pharmacology
54. The tryptophan metabolite picolinic acid suppresses proliferation and metabolic activity of CD4+ T cells and inhibits c-Myc activation
    Johanna Prodinger, Lisa J Loacker, Ralf L. J. Schmidt, Franz Ratzinger, Georg Greiner, Nadine Witzeneder, Gregor Hoermann, Sabrina Jutz, Winfried Franz Pickl, Peter Steinberger et al. · 2015 · Journal of Leukocyte Biology
55. The absence of indoleamine 2,3-dioxygenase expression protects against NMDA receptor-mediated excitotoxicity in mouse brain.
    G. Mazarei, David P. Budac, G. Lu, Hong J. Lee, Thomas Möller, B. R. Leavitt · 2013 · Experimental Neurology
56. Huntingtons Disease Mice Infected with Toxoplasma gondii Demonstrate Early Kynurenine Pathway Activation, Altered CD8+ T-Cell Responses, and Premature Mortality
    David W. Donley, Andrew R. Olson, Merl F. Raisbeck, Jonathan H. Fox, Jason P. Gigley · 2016 · PLoS ONE
57. Pharmacologic Induction of Endotoxin Tolerance in Dendritic Cells by L-Kynurenine
    Giorgia Manni, Giada Mondanelli, Giulia Scalisi, Maria Teresa Pallotta, Dario Nardi, Eleonora Padiglioni, Rita Romani, Vincenzo Nicola Talesa, Paolo Puccetti, Francesca Fallarino et al. · 2020 · Frontiers in Immunology
58. Effect of VGLUT inhibitors on glutamatergic synaptic transmission in the rodent hippocampus and prefrontal cortex
    Stuart A. Neale, Caroline S. Copeland, T.E. Salt · 2013 · Neurochemistry International
59. Quinolinic acid induces disrupts cytoskeletal homeostasis in striatal neurons. Protective role of astrocyte–neuron interaction
    Paula Pierozan, Fernanda da Silva Ferreira, Bárbara Ortiz de Lima, Regina Pessoa‐Pureur · 2014 · Journal of Neuroscience Research
60. The antidepressant effects of GM-CSF are mediated by the reduction of TLR4/NF-ĸB-induced IDO expression
    Sara Hemmati, Mohammad Amin Sadeghi, Razieh Mohammad Jafari, Hasan Yousefi‐Manesh, Ahmad Reza Dehpour · 2019 · Journal of Neuroinflammation
61. NO scavenging by 3-hydroxyanthranilic acid and 3-hydroxykynurenine: N-nitrosation leads via oxadiazoles to o-quinone diazides.
    Claudia Backhaus, Hafizur Rahman, Sebastian Scheffler, H. Laatsch, R. Hardeland · 2008 · Nitric oxide
62. In Situ Produced 7-Chlorokynurenate Provides Protection against Quinolinate- and Malonate-Induced Neurotoxicity in the Rat Striatum
    Paolo Guidetti, Hui‐Qiu Wu, Robert M. Schwarcz · 2000 · Experimental Neurology
63. ?-4-?hlorokynurenine Attenuates Kainate-Induced Seizures and Lesions in the Rat
    Hui-Qui Wu · 2002 · Experimental Neurology
64. Randomized, double-blind, placebo-controlled, dose-escalation study: Investigation of the safety, pharmacokinetics, and antihyperalgesic activity of L-4-chlorokynurenine in healthy volunteers
    Mark S. Wallace, Alexander White, Kathy A. Grako, Randal Lane, Allen Cato, H. Ralph Snodgrass · 2017 · Scandinavian Journal of Pain
65. Kynurenic acid accumulation underlies learning and memory impairment associated with aging
    Mihir Vohra, George A. Lemieux, Lin Lin, Kaveh Ashrafi · 2018 · Genes & Development
66. Genetic variants of the kynurenine-3-monooxygenase and postpartum depressive symptoms after cesarean section in Chinese women
    Saiying Wang, Kaiming Duan, Xiao-Fang Tan, Ji‐Ye Yin, Xiao‐Yuan Mao, Wei Zheng, Chunyan Wang, Mi Yang, Cheng Peng, Hong‐Hao Zhou et al. · 2017 · Journal of Affective Disorders
67. Indoleamine 2,3-Dioxygenase-Dependent Neurotoxic Kynurenine Metabolism Contributes to Poststroke Depression Induced in Mice by Ischemic Stroke along with Spatial Restraint Stress
    Young-Soo Koo, Hyunha Kim, J. Park, Min Jae Kim, Y. Shin, B. Choi, Seo-Yeon Lee, H. Shin · 2018 · Oxidative Medicine and Cellular Longevity
68. Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid
    Edén Flores-Barrera, Daniel R. Thomases, Daryn K. Cass, Ajay Bhandari, Robert M. Schwarcz, John P. Bruno, Kuei Yuan Tseng · 2017 · Journal of Neuroscience
69. Picolinic acid modulates kainic acid-evoked glutamate release from the striatum in vitro
    Lynda M. Vrooman, Khem H. Jhamandas, Roland J. Boegman, Richard J Beninger · 1993 · Brain Research
70. Coordination Complex Formation and Redox Properties of Kynurenic and Xanthurenic Acid Can Affect Brain Tissue Homeodynamics
    Lenka Kubicová, Franz Hadaček, Gert Bachmann, Wolfram Weckwerth, Vladimı́r Chobot · 2019 · Antioxidants
71. A novel kynurenic acid analog (SZR104) inhibits pentylenetetrazole-induced epileptiform seizures. An electrophysiological study
    Ildikó Demeter, Károly Nagy, Levente Gellért, László Vécsei, Ferenc Fülöp, József Toldi · 2012 · Journal of Neural Transmission
72. Uptake of 3-hydroxykynurenine measured in rat brain slices and in a neuronal cell line
    Clifford L. Eastman, Tomás R. Guilarte, John R. Lever · 1992 · Brain Research
73. Neuroinflammation and Neurodegeneration
    Inelia Morales, Gonzalo A. Farias, Nicole Cortés, Ricardo Benjamin Maccioni · 2016 · InTech eBooks
74. Modification of Kynurenine Pathway via Inhibition of Kynurenine Hydroxylase Attenuates Surgical Brain Injury Complications in a Male Rat Model
    G. Zakhary, P. Sherchan, Qian Li, Ji-Ping Tang, John H. Zhang · 2019 · Journal of Neuroscience Research
75. Minocycline as adjunctive treatment for treatment-resistant depression: study protocol for a double blind, placebo-controlled, randomized trial (MINDEP2)
    Muhammad Ishrat Husain, Clare Cullen, Madeha Umer, Andre F. Carvalho, Stefan M. Kloiber, Jeffrey H. Meyer, Abigail Ortiz, Yuliya Knyahnytska, Muhammed Omair Husain, Justine L. Giddens et al. · 2020 · BMC Psychiatry
76. Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
    Hirohiko Hikichi, Tetsuaki Hiyoshi, Toshiyuki Marumo, Yasumitsu Tomishima, Ayaka Kaku, Izumi Iida, Hiroki Urabe, Tomoko Tamita, Akito Yasuhara, Jun-ichi Karasawa et al. · 2015 · Journal of Pharmacological Sciences
77. The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia
    Angelika Richter, Melanie Hamann · 2003 · European Journal of Pharmacology
78. Antagonism of kynurenine-induced seizures by picolinic, kynurenic and xanthurenic acids
    Izyaslaw P. Lapin · 1983 · Journal of Neural Transmission
79. A Novel p.Glu298Lys Mutation in the ACMSD Gene in Sporadic Parkinson’s Disease
    Dolores Vilas, Rubén Fernández‐Santiago, Elena Sanchez, Luis J. Azcona, Meritxell Santos-Montes, Pilar Casquero, Lucía Argandoña, EDUARDO S. TOLOSA, Coro Paisán‐Ruiz · 2017 · Journal of Parkinson s Disease
80. Kynurenic Acid Prevents Cytoskeletal Disorganization Induced by Quinolinic Acid in Mixed Cultures of Rat Striatum
    Paula Pierozan, Helena Biasibetti, Felipe Schmitz, Fernanda Silva Ferreira, Regina Pessoa‐Pureur, Ângela Terezinha de Souza Wyse · 2017 · Molecular Neurobiology
81. Epigenetic Regulation by Agonist-Specific Aryl Hydrocarbon Receptor Recruitment of Metastasis-Associated Protein 2 Selectively Induces Stanniocalcin 2 Expression
    Aditya Joshi, Ekram Hossain, Cornelis J. Elferink · 2017 · Molecular Pharmacology
82. The IDO genetic polymorphisms and postpartum depressive symptoms: an association study in Chinese parturients who underwent cesarean section
    Kaiming Duan, Saiying Wang, Ji‐Ye Yin, Xi Li, Jiahui Ma, Zhendong Huang, Ying Zhou, He‐Ya Yu, Mi Yang, Hong‐Hao Zhou et al. · 2018 · Archives of Women s Mental Health
83. Histological and ultrastructural changes in the rat brain following systemic administration of picolinic acid
    Mirosław Beskid, J Jachimowicz, A Taraszewska, D. Kukulska · 1995 · Experimental and Toxicologic Pathology
84. Prolonged therapy with antidepressants increases hippocampal level of kynurenic acid and expression of Kat1 and Kat2 genes
    Tomasz Kocki, Ewa M. Urbańska, Janusz Kocki, Renata Kloc, Katarzyna Kocka, Marcin Olajossy, Björn Owe‐Larsson · 2018 · Pharmacological Reports
85. Celecoxib augmentation of escitalopram in treatment-resistant bipolar depression and the effects on Quinolinic Acid
    Monica Feliz R. Castillo, Stephen Murata, Markus Schwarz, Gregor A. Schütze, Natalie Moll, Brendan Martin, Bianca Burger, Elif Weidinger, Norbert Mueller, Angelos E Halaris · 2019 · Neurology Psychiatry and Brain Research
86. Lipopolysaccharide Increases Cortical Kynurenic Acid and Deficits in Reference Memory in Mice
    Lee Peyton, Alfredo Oliveros, Maximilian Tufvesson‐Alm, Lilly Schwieler, Phillip A. Starski, Göran Engberg, Sophie Erhardt, Doo‐Sup Choi · 2019 · International Journal of Tryptophan Research
87. The role of kynurenine pathway and kynurenic aminotransferase alleles in postpartum depression following cesarean section in Chinese women
    Chengxuan Quan, Saiying Wang, Kaiming Duan, Jiahui Ma, He‐Ya Yu, Mi Yang, Na Hu, Ge Long, Guang Zeng, Zhendong Huang · 2020 · Brain and Behavior
88. Absence of microglia or presence of peripherally‐derived macrophages does not affect tau pathology in young or old hTau mice
    Keying Zhu, Melanie Pieber, Jinming Han, Klas Blomgren, Xing‐Mei Zhang, Robert Adam Harris, Harald Lund · 2020 · Glia
89. Imaging cerebral tryptophan metabolism in brain tumor-associated depression
    Edit Bosnyák, David Olayinka. Kamson, Michael E. Behen, Geoffrey R. Barger, Sandeep Mittal, Csaba Juhász · 2015 · EJNMMI Research
90. Transport of Xanthurenic Acid by Rat/Human Organic Anion Transporters OAT1 and OAT3
    Yuichi Uwai, Emi HONJO · 2013 · Bioscience Biotechnology and Biochemistry
91. Comparative genotoxicity of 3-hydroxyanthranilic acid and anthranilic acid in the presence of a metal cofactor Cu (II) in vitro
    Gopi S. Gadupudi, King‐Thom Chung · 2011 · Mutation Research/Genetic Toxicology and Environmental Mutagenesis
92. Polymorphism of Kynurenine Pathway-Related Genes, Kynurenic Acid, and Psychopathological Symptoms in HIV
    Vanessa Douet, Naomi Tanizaki, Adrian A. Franke, Xingnan Li, Linda Chang · 2016 · Journal of Neuroimmune Pharmacology
93. Influence of picolinic acid on seizure susceptibility in mice
    Anna Cioczek‐Czuczwar, Piotr Czuczwar, Waldemar Andrzej Turski, Jolanta Parada-Turska · 2016 · Pharmacological Reports
94. Novel Therapeutic Targets for Major Depressive Disorder
    Max A. Lazar, Roger S. McIntyre · 2019 · Elsevier eBooks
95. Studies of the Association between the Kynurenine-3-Monooxygenase Gene and Depression
    Т. В. Лежейко, Вера Евгеньевна Голимбет, A. V. Andryushchenko, A. Melik-Pashayan, E. V. Mironova · 2018 · Neuroscience and Behavioral Physiology
96. Cinnabarinic Acid was Formed in Damaged Mitochondria and its Effect on Mitochondrial Respiration
    Youichi Nagamura, Kentaro Uesugi, J. Naito, Isao Ishiguro · 1999 · Advances in experimental medicine and biology
97. Association of kynurenine-3-monooxygenase gene with schizophrenia
    Вера Евгеньевна Голимбет, Т. В. Лежейко, М. В. Алфимова, Lilia I. Abramova, Nikolai Kondratev · 2014 · Russian Journal of Genetics
98. Gemst: a taylor-made combination that reverts neuroanatomical changes in stroke
    Arturo Mangas, Javier Yajeya, N. González, I. Ruiz, Marianny Pernía, M. Geffard, Rafael Coveñas · 2017 · European Journal of Histochemistry
99. Effects of Rofecoxib or Naproxen vs Placebo on Alzheimer Disease Progression: A Randomized Controlled Trial
    Aisen, Paul S., Schafer, Kimberly A., Grundman, Michael, Pfeiffer, Eric, Sano, Mary, Davis, Kenneth L., Farlow, Martin R., Jin, Shelia, Thomas, Ronald G., Thal, Leon J. et al. · 2003 · JAMA
100. Inflammatory Abnormalities in Major Depressive Disorder
     Gaurav Singhal, Bernhard T. Baune · 2019 · Elsevier eBooks
101. Correction: Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: evidence for an immune-modulated glutamatergic neurotransmission?
     Johann Steiner, Martin Walter, Tomasz Gos, Gilles J. Guillemin, Hans‐Gert Bernstein, Zóltan Sarnyai, Christian Mawrin, Ralf Brisch, Hendrik Bielau, Louise M zu Schwabedissen et al. · 2013 · Journal of Neuroinflammation
102. A67 RAPID REDUCTION IN ANXIETY SCORES IN IBD PATIENTS AFTER INFLIXIMAB INFUSION IS ASSOCIATED WITH CHANGES IN KYNURENINE/TRYPTOPHAN METABOLISM
     Caroline Seiler, Christian Avila, R Khana, Erika Springer, C. James, David Armstrong, John Kenneth Marshall, Stephen Michael Collins, María Inés Pinto-Sánchez, Premsyl Bercik · 2018 · Journal of the Canadian Association of Gastroenterology